The newly formed Business Advancement Center for Health (BACH) was excited to host the 4th annual Convene Conference in 2022 exploring consumerism in healthcare and the evolution of digital health from patient and provider perspectives. Leaders from the provider, payer, technology and regulatory sectors addressed how innovations can transform access, quality, and health equity. This half-day virtual conference featured dynamic sessions with influential healthcare leaders from across the United States featuring a keynote by Aneesh Chopra, President of CareJourney and former U.S. Chief Technology Officer for President Obama.
Welcome & Keynote: Aneesh Chopra
Aneesh Chopra, President of CareJourney, reflected on the importance of Open Data and API systems, the availability of Medicare and Medicaid data in the open market, and how data from personal devices can be leveraged to improve health, systems, and the consumer experience. Learn about Mr. Chopra's 5 key insights on how to improve consumerism in healthcare and the role technology plays.
Panel: Reaching the Healthcare Consumer
Panelists from Best Buy, Walmart, McKinsey & Company, and Medtronic discussed the role of virtual health services in reaching the healthcare consumer. Learn how these organizations adapted to the changing market caused during the COVID-19 pandemic, and how they are using technology to play a bigger role in the monitoring and care of healthcare consumers.
Executive Spotlight: Susan Silbermann
Susan Silbermann, former Global President of Emerging Markets at Pfizer (retired), discussed the lessons learned from the COVID-19 pandemic and how she navigated her long career at Pfizer in various roles across the globe. Learn how the rapid development and distribution of Pfizer's COVID-19 vaccine would not have been possible without collaborative work among stakeholders.
Panel: Enhancing the Consumer Experience in Healthcare
Panelists from Press Ganey, Mayo Clinic, Optum Digital, and the School of Public Health discussed the shift in consumer expectations through the COVID-19 pandemic. Learn how technology can advance the healthcare experience by eliminating the fragmentation that can exist in care delivery, and the power of algorithms in treatment processes can help to deliver better health outcomes in the future.
In 2021, MILI hosted the first virtual Convene Conference over 3 days in April. The theme, Health Equity: The Hill We Climb, inspired by Amanda Gorman's poem during the 2021 inauguration of President Biden, focused on the role of data in driving change in the healthcare system specifically around mental health, health equity, and social determinants of health. Each day of Convene explored the drivers and solutions that impact health equity in different areas of healthcare.
Recordings: April 19, 2021
Recordings: April 20, 2021
Recordings: April 21, 2021
Watch the recorded presentations from the third day of Convene: Innovation and Implementation of Solutions to Address Health Equity and Social Determinants of Health
Dr. Cara James, moderated by Dr. Archelle Georgiou
Paurvi Bhatt, Dr. Kristine Fortman, Abner Mason, and moderated by Monica Engel
Please read the full summary here: Convene 2019 Summary
Over 200 attendees and a host of industry experts, healthcare practitioners, and academic luminaries convened at the University of Minnesota’s Carlson School of Management for the second annual Convene Conference in September 2019. Sri Zaheer, dean of the Carlson School, and Pinar Karaca-Mandic, conference host and academic director of the Medical Industry Leadership Institute, welcomed the crowd on the 100th birthday of the business school, invoking its venerable intellectual tradition by linking this conference with the institution’s guiding commitment to business as a force for good. Measuring the ROI of artificial intelligence in healthcare was certainly not a founding concern, yet today the Carlson School’s extended expert community is poised to work within and lead in the technological development, regulation, and measurement of this key data analytic space.
- Dr. Kaveh Safavi, Managing Director and Head of Global Health Practice, Accenture
Kaveh Safavi, senior managing director of global healthcare at Accenture, started the day on a reassuring note: No matter what you’ve heard, the robots aren’t coming for your job. Instead, in the healthcare field, AI is allowing for the off-loading of routine tasks, so that humans can focus their limited time and energy on the judgement- and experience-based tasks in need of our responsive, abstract, creative, social, and hands-on expertise. By training and targeting AI to build our healthcare system’s capacity, we can increase productivity without sacrificing jobs—or the human touch that is so inextricably bound with high-quality healthcare.
- Dr. Kevin Croston, CEO, North Memorial Health
- Dr. Craig E. Samitt, President and CEO, Blue Cross and Blue Shield of Minnesota
- Dr. Penny Wheeler, President and CEO, Allina Health
- Moderator: Dr. Jakob Tolar, Medical School Dean and Vice President of Clinical Affairs, University of Minnesota
We know that AI can meaningfully transform healthcare settings: it can better allocate scant resources, improve clinical outcomes and workflows, and even enhance patients’ experiences. But it’s scary. This panel featured Craig Samitt, president and CEO of Blue Cross and Blue Shield of Minnesota, Penny Wheeler, president and CEO of Allina Health, and Kevin Croston, CEO of North Memorial Health, with moderation by Jakub Tolar, dean and vice president for clinical affairs at the University of Minnesota’s Medical School. Amid the opportunities these experts identified, they also identified financial barriers, dataset limitations, and misaligned incentives as major barriers to implementing AI and machine learning. If AI’s healthcare promise is to be realized, healthcare organizations must develop new models that better align financial incentives to leverage AI technologies in the clinical setting.
- Achin Bhowmik, PhD, Chief Technology Officer and Executive Vice President of Engineering, Starkey Hearing Technologies
- Tarek Haddad, Technical Fellow and Senior Manager of Predictive Analytics & Statistics Group, Medtronic
- Ralph Hall, JD, Principal, Leavitt Partners, Professor of Practice, University of Minnesota Law School
- Shaye Mandle, JD, President and CEO, Medical Alley
- Moderator: Dr. Susan Alpert, Executive in Residence, Medical Industry Leadership Institute
Silicon Valley tech giants may urge disruptors to “move fast and break things,” but healthcare is not a venue that embraces either. Nor should it be—hence the multifaceted regulatory environment scaffolding this sector. But when technology moves fast anyway, regulations can get murky, ill-fitted, or overridden. Panelists Achin Bhowmik, CTO and executive vice president of engineering for Starkey Hearing Technologies, Tarek Haddad, of Medtronic’s R&D group, University of Minnesota Law School professor Ralph Hall, and Shaye Mandle, president and CEO of The Medical Alley Association, joined moderator Susan Alpert, MILI’s executive in residence, for a wide-ranging discussion on the FDA’s evolving relationship with AI and machine learning tools in healthcare administration and practice. Technology will reshape data ownership, ethics, and legal liability, and leaders will do well to recognize that the lag between innovation and regulation is a time rife with potential pitfalls.
- Lisa Suennen, Lead Manatt Ventures and Digital & Technology Group, Managing Partner, Venture Valkyrie LLC
- Moderator: Dr. Archelle Georgiou, Industry Advisor and Executive in Residence, Medical Industry Leadership Institute
Lisa Suennen is a self-proclaimed AI cynic. The entrepreneur is a venture capital partner with Manat, Phelps, & Phillips LLP, and she has seen plenty of AI speculation come and go over the last 20 years. Suennen, interviewed by fellow entrepreneur and MILI Industry Advisor Archelle Georgiou, urged innovators to keep their focus on the problems they aim to solve, rather than being seduced by new technology. Lisa emphasized two critical success factors: multidisciplinary teams and early investment in the economic value of a technology solution. By the end, Suennen admitted that while she is cynical in the short term, she is a long-term AI optimist who expects to see AI mainstreamed within a decade.
- Jodi Hubler, Managing Director, Lemhi Ventures
- Jon Pearce, CEO, Zipnosis
- Jack Schneeman, Co-CEO, Phraze
- Moderator: Michael Finch, PhD, Executive in Residence, Medical Industry Leadership Institute
The healthcare industry has been traditionally slow to change because when people’s lives are on the line, there’s inherently more risk to upending tried and true methods for machine learning and other AI innovations. And as panelists Jodi Hubler, managing director with Lemhi Ventures, Jon Pearce, CEO of Zipnosis, and Jack Schneeman, Co-CEO of Phraze explored with moderator Michael Finch, MILI executive in residence, AI integration requires organizations to seamlessly insert themselves at the intersection of data flow and clinical decision-making. This takes time to and contributes to healthcare’s “tortoise” tendencies. But the delay may open opportunity, since those who jump in too early may waste time on tweaks to flawed tech, while those who wait can transform entire sectors with proven systems.
- Michael Ramlet, Co-Founder and CEO, Morning Consult
- Moderator: Stephen T. Parente, PhD, Professor, Carlson School of Management
In the day’s final session, we turned the executive spotlight to Michael Ramlet, CEO of Morning Consult. What began as an industry-focused newsletter in Ramlet’s undergraduate years at the University of Minnesota evolved into one of the country’s premiere bipartisan health data companies, providing statistics and analysis on over 3,700 brands and translating “CTO-speak” to actionable findings for healthcare practitioners, regulators, analysts, and innovators. Now, the data guru who described being “young and dumb enough” to collect data is guiding global conversations that ultimately return to the idea that any innovation, any AI tech, is only as good as the data behind it.
Please read the full summary here: Convene 2018 Summary
- Archelle Georgiou, MD, Conference Moderator, Industry Advisor, Medical Industry Leadership Institute, Carlson School of Management
Cognitive technologies are rapidly evolving to imitate human intelligence, augmenting and even, in some cases, replacing human decision-making. These advances are heralded, yet Convene 2018 asked a pressing question: what tensions and consequences arise when human intelligence intersects with artificial intelligence?
Since these tensions exist throughout the lifecycle of advanced analytics, from development to reimbursement, the CONVENE agenda was purposefully crafted around three specific goals:
- How to BUILD technologies to improve health without causing harm
- How to USE tools to enhance care while avoiding disruptions to care and workflow processes
- How to PAY for the enhanced care guidance informed by predictive analytics while avoiding the cost and risk of non-value added services.
Each goal was addressed in a uniquely curated session that included a University of Minnesota faculty member as well as an industry executive. Then, a skilled moderator probed into each speaker’s point of view during a panel discussion. Tremendous value was created as academicians were enlightened by business realities and executives were informed by research evidence. This dual insight, in fact, is key to Convene: insights become innovation and innovation leads to positive, sustainable change when teaching, learning, and listening all converge.
- Dr. Bridget Duffy, Chief Medical Officer, Vocera Communications, Inc.
As healthcare stakeholders urge leaner operations and technology and ever-evolving data sources suggest more personalized, individualized care, health practitioners are getting burned out. Some 73% of doctors say they wouldn’t encourage their children to follow in their footsteps. Patients, too, are exhausted, sensing, as they fill out form after form, that even when it comes to their health, they are little more than a number. How can we right this ship? By realizing that, for every inefficiency we identify and strip from the healthcare system, we must reinsert a point of empathy and care, for patients and practitioners alike.
Humanizing healthcare for the system’s sustainability and better patient outcomes means re-centering clinical practice to include paying careful attention to human-to-human interaction, the experience of the physical space of caregiving, and yes, even allowing room for spirituality. Dr. Bridget Duffy presented ten steps for reforms, suggesting that innovators focus on changes that build trust and emphasize humanity as avidly as they create and leverage data. Through technology and interdisciplinary teamwork, we can both accelerate and ease change in the healthcare landscape, for patients and clinicians alike.
- Randy Schiestl, Vice President, R&D, Global Technology & Services, Boston Scientific Corporation
- Steve Johnson, PhD, Assistant Professor, Institute of Health Informatics, University of Minnesota
- Moderator: Aylin Altan, PhD, Senior Vice President of Research, OptumLabs
When we create new medical devices, the analytics—the metrics by which we measure success and failure and refine each iteration—are built in from the start. But what about when we create new data systems? Randy Scheistl explained how only good data can be a good guide when it comes to creating holistic, effective, and empathetic systems of care. And, as Steve Johnson put it, gathering good data requires building a solid foundation and custodial oversight into data collection and regularly measuring and refining the efficacy of our data collection. For Johnson, interoperability of innovative data systems will be key in making big data good data.
- Kurt Waltenbaugh, Founder, Carrot Health
- Lana Yarosh, PhD, Assistant Professor, Computer Science & Engineering, University of Minnesota
- Moderator: Per Hong, Partner, A.T. Kearney
When Twitter trends and Google searches can detect flu outbreaks before the CDC, it’s clear that good data can come from unexpected sources. Kurt Waldenbaugh of Carrot Health explained how data from social media, real estate transactions, consumer purchasing and other non-traditional sources can be used to predict healthcare risk –personalized, targeted risk – better than traditional claims data systems and actuarial data. Carrot Health is collecting data on the entire US population and mapping the uneven distribution of health outcomes by geography to tease out the associations that best nudge specific patient groups toward healthier living. Lana Yarosh discussed how to glean insights from unstructured text and focused on her analysis of one million journal entries from CaringBridge.org, a website that allows patients and their families to share healthcare information with friends and relatives. Using natural language processing techniques, she identified actionable insights regarding patients’ healthcare journeys. Though Waldenbaugh and Yarosh cautioned that nontraditional data sources have challenges and limitations including accuracy, privacy, and interpretation, both agree that these data sources can meaningfully inform personalized care.
- Darrell Johnson, Vice President Business Solution Data Science, Medtronic
- Genevieve Melton-Meaux, MD, PhD, Professor, Institute for Health Informatics, University of Minnesota
- Moderator: Rahul Koranne, MD, Chief Medical Officer, Minnesota Hospital Association
Medtronic’s Bart Phillips is quick to point out that, even as devices shrink, the data they are providing has ballooned. To the applied statistician, that has meant calling for more actionable data, not just more data, if the cost-savings potential of predictive analytics is to come to fruition. Genevieve Melton-Meaux, a colorectal surgeon and Fairview M Health’s Chief Data and Informatics Officer, spoke about using that actionable data in practice, emphasizing the need to build profitability in a landscape of eroding margins. Ultimately, by accurately collecting, communicating, analyzing, and acting upon patient data through artificial intelligence systems, providers become not basement-dwelling IT shops, but highly informed and cost efficient vehicles for ever-improving patient outcomes. As moderator Rahul Koranne pointed out, healthcare is on track to become 25% of the nation’s GDP—but the ROI for AI-informed healthcare remains unknown. Transparency across health systems may be key in building better AI and better health along the way.
- Hannah Neprash, PhD, Assistant Professor, Division of Health Policy & Management, University of Minnesota
- Garrett Black, Senior Vice President of Health Services and Enterprise Solutions, Blue Cross and Blue Shield of Minnesota
- Moderator: Charles Boorady, Founding Managing Director, Health Catalyst Capital Management LLC
When a retinopathy machine needs only a minute to diagnose a patient, Hannah Neprash explained, the three components of healthcare reimbursement are unprepared to determine its value—and health-related AI is proliferating. Blue Cross and Blue Shield of Minnesota’s Garrett Black deftly carried this insight into a discussion of recentering reimbursement by focusing on value-based healthcare, so that the cost-savings resulting from using social data to inform care and increase treatment adherence accrue and patients’ access is eased. That is, if AI’s increased precision can attend to the social determinants of health in ways that result in healthier communities and lowered costs, reimbursers’ bundled payments and performance schemes can support the effort to all patients’ benefit.
- John Hammergren,Chairman, President, and Chief Executive Officer, McKesson Corporation
- Moderator: Stephen T. Parente, PhD, Professor, Department of Finance, Minnesota Insurance Industry Chair of Health Finance, Carlson School of Management
In Convene’s concluding panel, the U’s Steve Parente and McKesson’s Chair and CEO John Hammergren were joined by Archelle Georgiou to discuss the future of health care and data analytics. Key insights included the need for collaborative leadership from business, academia, practitioners, and regulators, as well as daring innovation of the kind that leads to entirely new systems, rather than add-on products that render change iterative, rather than transformative.